Micromet | Evaluate

September 19, 2016

Deal flurry shines spotlight on novel multiple myeloma target

September 02, 2016

Behold the son of Blincyto

December 04, 2014

Amgen leukaemia drug zooms to US launch

November 28, 2014

ASH preview – Stock-moving for some, damp squib for others

March 28, 2014

Upcoming events: blinatumomab data and US decision on Alprolix

February 07, 2013

M&A activity cools in 2012 as break-ups loom

May 14, 2012

EP Vantage Interview - F-Star to push forward with bispecific antibody pipeline

March 15, 2012

Interview - Affimed hoping to crank up the pace

February 01, 2012

Average M&A deal values recover in 2011

January 31, 2012

M&A deal activity dims in 2011 as big pharma backs off

January 26, 2012

Amgen BiTEs at the chance to buy Micromet

Load More